Valproate/Lamotrigine and Growth Retardation
Growth and bone metabolism were evaluated in 27 boys and 26 girls, aged 3 to 17 years (mean 9.2 yrs), with epilepsy treated with valproate (VPA) and/or lamotrigine (LTG) for >2 years, in a study at McMaster University and Children's Hospital, Hamilton, Ontario, Canada.
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | |
| Опубликовано: |
Pediatric Neurology Briefs Publishers,
2001-12-01T00:00:00Z.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Копировать 1 | Доступно |